Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Nov;14(5):771–779. doi: 10.1128/aac.14.5.771

Characterization of a Bacteriocinogenic Plasmid in Clostridium perfringens CW55

Valerie A Mihelc 1, Charles L Duncan 1,†, Glenn H Chambliss 1
PMCID: PMC352549  PMID: 215082

Abstract

A bacteriocinogenic strain of Clostridium perfringens was exposed to various curing agents known to accelerate the elimination of extrachromosomal DNA, and 20 independently derived mutants that had lost both the ability to produce bacteriocin and their immunity to it were isolated and characterized. All of the mutants were missing at least two specific plasmid bands seen in the agarose gel plasmid profile of the parent strain. Evidence that the two missing bands represented the open circular and closed circular forms of the same plasmid was obtained by X-ray nicking and restriction endonuclease digestion. The data indicated that bacteriocin production and immunity are controlled by a single plasmid, pCW4, with a molecular weight of 5.6 × 106 in this strain. Attempts to transfer the bacteriocinogenic plasmid were unsuccessful.

Full text

PDF
771

Images in this article

774Image
on p.774
776Image
on p.776
777Image
on p.777

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bazaral M., Helinski D. R. Circular DNA forms of colicinogenic factors E1, E2 and E3 from Escherichia coli. J Mol Biol. 1968 Sep 14;36(2):185–194. doi: 10.1016/0022-2836(68)90374-4. [DOI] [PubMed] [Google Scholar]
  2. Brefort G., Magot M., Ionesco H., Sebald M. Characterization and transferability of Clostridium perfringens plasmids. Plasmid. 1977 Nov;1(1):52–66. doi: 10.1016/0147-619x(77)90008-7. [DOI] [PubMed] [Google Scholar]
  3. Clewell D. B., Helinski D. R. Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an opern circular DNA form. Proc Natl Acad Sci U S A. 1969 Apr;62(4):1159–1166. doi: 10.1073/pnas.62.4.1159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hardy K. G. Colicinogeny and related phenomena. Bacteriol Rev. 1975 Dec;39(4):464–515. doi: 10.1128/br.39.4.464-515.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ionesco H., Bieth G., Dauguet C., Bouanchaud D. Isolement et identification de deux plasmides d'une souche bactériocinogène de Clostridium perfringens. Ann Microbiol (Paris) 1976 Oct;127B(3):283–294. [PubMed] [Google Scholar]
  6. Ionesco H., Bouanchaud D. H. Production de bactériocine liée à présence d'un plasmide chez Clostridium perfringens type. C R Acad Sci Hebd Seances Acad Sci D. 1973 May 14;276(20):2855–2857. [PubMed] [Google Scholar]
  7. Ionesco H., Wolff A., Sebald Production induite de bactériocine et d'un bactériophage par la souche BP6K-N-5 de Clostridium perfringens. Ann Microbiol (Paris) 1974 Oct-Nov;125B(3):335–346. [PubMed] [Google Scholar]
  8. Ionesco H., Wolff A. Sur le mode d'action de la bactériocine N5 purifiée de Clostridium perfringens. C R Acad Sci Hebd Seances Acad Sci D. 1975 Dec 22;281(24):2033–2036. [PubMed] [Google Scholar]
  9. Kontomichalou P., Mitani M., Clowes R. C. Circular R-factor molecules controlling penicillinase synthesis, replicating in Escherichia coli under either relaxed or stringent control. J Bacteriol. 1970 Oct;104(1):34–44. doi: 10.1128/jb.104.1.34-44.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mahony D. E. Bacteriocin susceptibility of Clostridium perfringens: a provisional typing schema. Appl Microbiol. 1974 Aug;28(2):172–176. doi: 10.1128/am.28.2.172-176.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mahony D. E., Butler M. E. Bacteriocins of Clostridium perfringens. 1. Isolation and preliminary studies. Can J Microbiol. 1971 Jan;17(1):1–6. doi: 10.1139/m71-001. [DOI] [PubMed] [Google Scholar]
  12. Mahony D. E., Butler M. E., Lewis R. G. Bacteriocins of Clostridium perfringens. 2. Studies on mode of action. Can J Microbiol. 1971 Nov;17(11):1435–1442. doi: 10.1139/m71-228. [DOI] [PubMed] [Google Scholar]
  13. Meyers J. A., Sanchez D., Elwell L. P., Falkow S. Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid. J Bacteriol. 1976 Sep;127(3):1529–1537. doi: 10.1128/jb.127.3.1529-1537.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nomura M. Colicins and related bacteriocins. Annu Rev Microbiol. 1967;21:257–284. doi: 10.1146/annurev.mi.21.100167.001353. [DOI] [PubMed] [Google Scholar]
  15. REEVES P. THE BACTERIOCINS. Bacteriol Rev. 1965 Mar;29:24–45. doi: 10.1128/br.29.1.24-45.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rood J. I., Maher E. A., Somers E. B., Campos E., Duncan C. L. Isolation and characterization of multiply antibiotic-resistant Clostridum perfringens strains from porcine feces. Antimicrob Agents Chemother. 1978 May;13(5):871–880. doi: 10.1128/aac.13.5.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rood J. I., Scott V. N., Duncan C. L. Identification of a transferable tetracycline resistance plasmid (pCW3) from Clostridium perfringens. Plasmid. 1978 Sep;1(4):563–570. doi: 10.1016/0147-619x(78)90013-6. [DOI] [PubMed] [Google Scholar]
  18. SMITH H. W. The bacteriophages of Clostridium perfringens. J Gen Microbiol. 1959 Dec;21:622–630. doi: 10.1099/00221287-21-3-622. [DOI] [PubMed] [Google Scholar]
  19. SZYBALSKI W., BRYSON V. Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. J Bacteriol. 1952 Oct;64(4):489–499. doi: 10.1128/jb.64.4.489-499.1952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sasarman A., Antohi M. Une nouvelle classe de welchicines. Rev Can Biol. 1971 Sep;30(3):183–189. [PubMed] [Google Scholar]
  21. Săsărman A., Antohi M. Données préliminares sur le transfert de la capacité welchicinogène de Clostridium perfringens à Bacillus anthracis. Arch Roum Pathol Exp Microbiol. 1969 Jun-Sep;28(2):743–745. [PubMed] [Google Scholar]
  22. Tubylewicz H. Antigenic properties of the bacteriocine preparations obtained from type A Cl. perfringens strains. Bull Acad Pol Sci Biol. 1970;18(5):253–256. [PubMed] [Google Scholar]
  23. Tubylewicz H. Experimental studies on bacteriocinogeneity in Cl. perfringens type A. 3. Chemical structure of isolated bacteriocines. Bull Acad Pol Sci Biol. 1968;16(5):279–284. [PubMed] [Google Scholar]
  24. Tubylewicz H. Experimental studies on bacteriocinogeneity in Clostridium perfringens type A. I. Isolation of bacteriocines and their antibacterial spectrum. Bull Acad Pol Sci Biol. 1966;14(1):31–36. [PubMed] [Google Scholar]
  25. Tubylewicz H. Experimental studies on the bacteriocinogeneity in Cl. perfringens type A. II. Properties of isolated bacteriocines. Bull Acad Pol Sci Biol. 1966;14(7):467–473. [PubMed] [Google Scholar]
  26. Wolff A., Ionesco H. Purification et caractérisation de la bactériocine N5 de Clostridium perfringens BP6K-N5 TYPE A. Ann Microbiol (Paris) 1975 Oct-Nov;126(3):343–356. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES